Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bruker Corporation - Common Stock (NQ:BRKR)

58.50 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8
Open 58.50
Bid (Size) 56.03 (100)
Ask (Size) 60.29 (200)
Prev. Close 58.50
Today's Range 58.50 - 58.50
52wk Range 29.84 - 65.30
Shares Outstanding 146,727,377
Dividend Yield 0.34%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
From Bruker Corporation
Via Business Wire
News headline image
3 Small-Cap Stocks We’re Skeptical Of
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory

Performance

YTD
+21.6%
+21.6%
1 Month
+3.9%
+3.9%
3 Month
+4.0%
+4.0%
6 Month
+57.3%
+57.3%
1 Year
+89.9%
+89.9%

More News

Read More
News headline image
Research Tools & Consumables Stocks Q2 Highlights: Bruker (NASDAQ:BRKR)
Via StockStory
Topics Economy
News headline image
3 Unpopular Stocks with Questionable Fundamentals
Via StockStory
News headline image
Bruker (BRKR) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings World Trade
News headline image
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
From Bruker Corporation
Via Business Wire
News headline image
The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call
Via StockStory
Topics Earnings World Trade
News headline image
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
From Bruker Corporation
Via Business Wire
News headline image
BRKR Q2 Deep Dive: Margin Expansion and Delayed Revenue Impact Market Sentiment
Via StockStory
Topics World Trade
News headline image
Bruker (BRKR) Stock Trades Down, Here Is Why
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Bruker Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings World Trade
News headline image
Bruker (NASDAQ:BRKR) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 11.9%
Via StockStory
News headline image
Bruker Reports Second Quarter 2026 Financial Results
From Bruker Corporation
Via Business Wire
News headline image
Earnings To Watch: Bruker (BRKR) Reports Q2 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Sell BRKR and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
News headline image
Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood
From Bruker Corporation
Via Business Wire
News headline image
3 Cash-Producing Stocks We’re Skeptical Of
Via StockStory
News headline image
Bruker (BRKR) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence
News headline image
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam ↗
Via MarketBeat
News headline image
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
From Bruker Corporation
Via Business Wire
News headline image
3 Small-Cap Stocks That Concern Us
Via StockStory
News headline image
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
From Bruker Corporation
Via Business Wire
News headline image
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
From Bruker Corporation
Via Business Wire
News headline image
Q1 Earnings Highs And Lows: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks
Via StockStory
Topics Economy

Frequently Asked Questions

Is Bruker Corporation - Common Stock publicly traded?
Yes, Bruker Corporation - Common Stock is publicly traded.
What exchange does Bruker Corporation - Common Stock trade on?
Bruker Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bruker Corporation - Common Stock?
The ticker symbol for Bruker Corporation - Common Stock is BRKR on the Nasdaq Stock Market
What is the current price of Bruker Corporation - Common Stock?
The current price of Bruker Corporation - Common Stock is 58.50
When was Bruker Corporation - Common Stock last traded?
The last trade of Bruker Corporation - Common Stock was at 09/04/26 04:00 PM ET
What is the market capitalization of Bruker Corporation - Common Stock?
The market capitalization of Bruker Corporation - Common Stock is 8.58B
How many shares of Bruker Corporation - Common Stock are outstanding?
Bruker Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS